Fingerprint
Dive into the research topics of 'Phase I study of navitoclax (ABT-263), a novel bcl-2 family inhibitor, in patients with small-cell lung cancer and other solid tumors'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically